芬太尼透皮贴用于子宫腺肌症的镇痛疗效观察

发布时间：2018-03-27 15:51

本文选题：子宫腺肌症　切入点：痛经　出处：《中日友好医院学报》2016年06期

【摘要】：目的:观察芬太尼透皮贴用于子宫腺肌症患者经期的镇痛效果。方法:将48例以严重痛经为主要临床症状的子宫腺肌症患者随机分为治疗组和对照组,前者采用芬太尼透皮贴镇痛;后者使用芬必得,均于月经来潮前3d开始用药至月经d3,共治疗3个月经周期。采用视觉模拟评分(VAS)法评价镇痛效果,同时记录治疗副反应。结果:2种方法对于子宫腺肌症重度痛经患者均有明显效果,但治疗组患者每疗程后VAS评分均较对照组低;且随着疗程增加,对照组镇痛效果逐渐减弱,治疗组镇痛效果无减退。结论:芬太尼透皮贴可以有效缓解子宫腺肌症患者痛经症状,简便易行,无明显不良反应,适合临床推广。
[Abstract]:Objective: To observe the analgesic effect of transdermal fentanyl for menstruating women with adenomyosis. Methods: 48 cases with severe dysmenorrhea were the main symptoms of the patients with adenomyosis were randomly divided into treatment group and control group, the former transdermal analgesia with fentanyl; the latter were using Fenbid, before menstruation began to 3D use D3 to menstruation, were treated for 3 menstrual cycles. Using visual analogue scale (VAS) method to evaluate the analgesic effect and side effects of the therapy and recorded. Results: 2 methods for adenomyosis dysmenorrhea patients had obvious effect, but the treatment group patients with VAS score after each course of treatment was lower than the control group; and with the the control group treatment increased the analgesic effect gradually weakened, the analgesic effect of the treatment group was not decreased. Conclusion: transdermal fentanyl can effectively alleviate the symptoms of dysmenorrhea in patients with adenomyosis, simple, no obvious adverse reaction, suitable for clinical Guangzhou.

【作者单位】：河北北方学院附属第二医院妇产科;中日友好医院妇产科;
【分类号】：R711.71

【相似文献】